Investor relations

We use the innovative power in combining material science and pharma,
revolutionizing drug delivery and giving patients a better and safer everyday life

We create new and innovative products with shorter time to market and mitigated risk.
We make this possible by combining material science & pharmaceutical development and by using established and approved active substances.

Press Releases

Financial Calendar

November 19 2021
Interim Report Q3 2021
February 22 2022
Year-end Report 2021

IR contact


Recieve press releases and reports via email.